Foresee Pharmaceuticals Co Ltd (6576) — Working Capital to Net Assets Ratio
Foresee Pharmaceuticals Co Ltd (6576) has a Working Capital to Net Assets ratio of 84.9% as of June 2025. Working capital of NT$825.40 Million (current assets of NT$1.26 Billion minus current liabilities of NT$429.69 Million) is measured against net assets of NT$971.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 6576 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Foresee Pharmaceuticals Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Foresee Pharmaceuticals Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 84.9%, reflecting working capital of NT$825.40 Million against net assets of NT$971.84 Million TWD. For the complete balance sheet picture, see 6576 total assets.
Annual Working Capital to Net Assets for Foresee Pharmaceuticals Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Foresee Pharmaceuticals Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 6576 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 89.1% | NT$1.42 Billion | NT$1.60 Billion | NT$1.82 Billion | NT$393.21 Million | ▼ -0.9 pp |
| 2023 | 90.0% | NT$1.12 Billion | NT$1.24 Billion | NT$1.59 Billion | NT$470.83 Million | ▲ +3.7 pp |
| 2022 | 86.3% | NT$785.89 Million | NT$910.58 Million | NT$915.06 Million | NT$129.17 Million | ▼ -6.8 pp |
| 2021 | 93.1% | NT$1.23 Billion | NT$1.32 Billion | NT$1.30 Billion | NT$74.45 Million | ▲ +7.6 pp |
| 2020 | 85.5% | NT$1.56 Billion | NT$1.83 Billion | NT$1.69 Billion | NT$121.59 Million | ▲ +31.0 pp |
| 2019 | 54.6% | NT$488.77 Million | NT$895.86 Million | NT$552.25 Million | NT$63.48 Million | ▲ +15.7 pp |
| 2018 | 38.8% | NT$193.71 Million | NT$498.62 Million | NT$318.38 Million | NT$124.67 Million | ▼ -40.7 pp |
| 2017 | 79.5% | NT$479.94 Million | NT$603.66 Million | NT$578.09 Million | NT$98.16 Million | — |